Genprex shareholders approve amended 2018 equity incentive plan at annual meeting

• Genprex held its annual shareholder meeting on June 18, 2026.
• Shareholders elected Jose Antonio Moreno Toscano and Ryan M. Confer as directors with terms running to the 2029 annual meeting.
• WithumSmith+Brown was ratified as independent registered public accounting firm for fiscal 2026.
• An amended 2018 equity incentive plan was adopted, increasing the share reserve by 1,850,000; the plan became effective upon approval.
• A charter amendment authorizing a potential reverse stock split from 1-for-5 to 1-for-50 by Dec. 31, 2027 was adopted; implementation remains at the board’s discretion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-021134), on June 18, 2026, and is solely responsible for the information contained therein.